cytarabine has been researched along with 24,25-dihydroxyvitamin d 3 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, ZC; Guo, H; Lei, Q; Li, QB; Lin, SY; Ren, WX; Zhang, L | 1 |
1 other study(ies) available for cytarabine and 24,25-dihydroxyvitamin d 3
Article | Year |
---|---|
Enhanced Response of Acute Monocytic Leukemia Cells to Low-dose Cytarabine by 1,25-dihydroxyvitamin D3.
Topics: 24,25-Dihydroxyvitamin D 3; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytarabine; Drug Synergism; Humans; Leukemia, Monocytic, Acute; Vitamins | 2018 |